Paul Kenna

Fundador en Spark Therapeutics Ireland Ltd. .

Consumer Services

Health Technology

Cargos activos de Paul Kenna

Empresas	Cargo	Inicio	Fin
Spark Therapeutics Ireland Ltd. Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.	Director Técnico/Científico/I+D	01/09/2004	-
	Fundador	-	-
Trinity College Dublin	Corporate Officer/Principal	-	-
The Royal College of Physicians	Corporate Officer/Principal	-	-
Irish College of Ophthalmologists	Corporate Officer/Principal	-	-

Trinity College Dublin

Doctorate Degree

Internacional

Irlanda	4
Reino Unido	2

Operativa

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Founder	1

Sectorial

Consumer Services	4
Health Technology	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	1
Spark Therapeutics Ireland Ltd. Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.	Health Technology

Empresas privadas

Health Technology